Citations (122)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Yan-Jie Cheng, Fan Fan, Zhong Zhang & Hai-jun Zhang. (2023) Lipid metabolism in malignant tumor brain metastasis: reprogramming and therapeutic potential. Expert Opinion on Therapeutic Targets 27:9, pages 861-878.
Read now
Read now
Alexandra S Zimmer, Seth M Steinberg, Dee Dee Smart, Mark R Gilbert, Terri S Armstrong, Eric Burton, Nicole Houston, Nadia Biassou, Brunilde Gril, Priscilla K Brastianos, Scott Carter, David Lyden, Stanley Lipkowitz & Patricia S Steeg. (2020) Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Future Oncology 16:14, pages 899-909.
Read now
Read now
Kelsey M Bowman & Priya Kumthekar. (2018) Medical Management of Brain Metastases and Leptomeningeal Disease in Patients with Breast Carcinoma. Future Oncology 14:4, pages 391-407.
Read now
Read now
Tyler Lazaro & Priscilla K Brastianos. (2017) Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine. CNS Oncology 6:2, pages 139-151.
Read now
Read now
Cagatay Arslan, Omer Dizdar & Kadri Altundag. (2014) Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update. Expert Opinion on Pharmacotherapy 15:12, pages 1643-1658.
Read now
Read now
Hamdy A Azim & Hatem A Azim Jr. (2012) Systemic Treatment of Brain Metastases in HER2-Positive Breast Cancer: Current Status and Future Directions. Future Oncology 8:2, pages 135-144.
Read now
Read now
Lois A. Lampson. (2011) Monoclonal antibodies in neuro-oncology. mAbs 3:2, pages 153-160.
Read now
Read now
Cagatay Arslan, Omer Dizdar & Kadri Altundag. (2010) Systemic treatment in breast-cancer patients with brain metastasis. Expert Opinion on Pharmacotherapy 11:7, pages 1089-1100.
Read now
Read now
Marc C Chamberlain. (2010) Anticancer therapies and CNS relapse: overcoming blood–brain and blood–cerebrospinal fluid barrier impermeability. Expert Review of Neurotherapeutics 10:4, pages 547-561.
Read now
Read now
Otto Metzger-Filho, Camilo Moulin, Evandro de Azambuja & Awada Ahmad. (2009) Larotaxel: broadening the road with new taxanes. Expert Opinion on Investigational Drugs 18:8, pages 1183-1189.
Read now
Read now
A Mukherjee, AS Dhadda, M Shehata & Stephen Chan. (2007) Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast cancer. Expert Opinion on Pharmacotherapy 8:13, pages 2189-2204.
Read now
Read now
Domenico Errante, Daniele Bernardi, Antonio Bianco & Luigi Salvagno. (2007) Comment on: Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncologica 46:4, pages 565-566.
Read now
Read now
Articles from other publishers (110)
Akshara S. Raghavendra & Nuhad K. Ibrahim. (2024) Breast Cancer Brain Metastasis: A Comprehensive Review. JCO Oncology Practice.
Crossref
Crossref
Sushant Puri, Amina Chaudhry, Asnakech Bayable, Ashwin Ganesh, Ahmad Daher, Vijayakrishna K. Gadi & Stefania Maraka. (2023) Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients. Current Oncology Reports 25:12, pages 1419-1430.
Crossref
Crossref
Yaning He, Yingbo Shao, Qi Chen, Chaojun Liu, Fangyuan Zhu & Hui Liu. (2023) Brain metastasis in de novo stage IV breast cancer. The Breast 71, pages 54-59.
Crossref
Crossref
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Sean A Grimm, Margaret Schwartz, Kirsten L Bell Burdett, Rimas V Lukas, Karan Dixit, Isabella Perron, Hui Zhang, William J Gradishar, Elena I Pentsova, Suriya Jeyapalan, Morris D Groves, Michelle Melisko & Jeffrey J Raizer. (2023) A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. Neuro-Oncology 25:3, pages 557-565.
Crossref
Crossref
Marius Müller, Vladimir Shalgunov, Lars Hvass, Jesper T. Jørgensen, Vasko Kramer, Markus Staudt, Umberto Maria Battisti, Andreas Kjaer & Matthias M. Herth. (2023) Synthesis and in vivo evaluation of [11C]tucatinib for HER2-targeted PET imaging. Bioorganic & Medicinal Chemistry Letters 80, pages 129088.
Crossref
Crossref
Fabienne Hamester, Christine Stürken, Karen Legler, Kathrin Eylmann, Katrin Möller, Maila Roßberg, Christian Gorzelanny, Alexander T. Bauer, Sabine Windhorst, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller, Isabell Witzel & Leticia Oliveira-Ferrer. (2022) Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer. Cells 11:20, pages 3275.
Crossref
Crossref
Melih Simsek, Altay Aliyev, Tuba Baydas, Mehmet Besiroglu, Tarik Demir, Abdallah TM Shbair, Mesut Seker & H. Mehmet Turk. (2022) Breast Cancer Patients with Brain Metastases: A Cross-Sectional Study. The Breast Journal 2022, pages 1-5.
Crossref
Crossref
Charlton Tsai, Bastien Nguyen, Anisha Luthra, Joanne F. Chou, Lara Feder, Laura H. Tang, Vivian E. Strong, Daniela Molena, David R. Jones, Daniel G. Coit, David H. Ilson, Geoffrey Y. Ku, Darren Cowzer, John Cadley, Marinela Capanu, Nikolaus Schultz, Kathryn Beal, Nelson S. Moss, Yelena Y. Janjigian & Steven B. Maron. (2022) Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma. JAMA Network Open 5:8, pages e2228083.
Crossref
Crossref
Alexandra S. Zimmer, Amanda E. D. Van Swearingen & Carey K. Anders. (2020)
HER2‐positive
breast cancer brain metastasis: A new and exciting landscape
. Cancer Reports 5:4.
Crossref
Crossref
Fabienne Hamester, Christine Stürken, Ceren Saygi, Minyue Qi, Karen Legler, Christian Gorzelanny, José R. Robador, Barbara Schmalfeldt, Elena Laakmann, Volkmar Müller, Isabell Witzel & Leticia Oliveira-Ferrer. (2022) Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier. International Journal of Molecular Sciences 23:3, pages 1900.
Crossref
Crossref
Hemavathy Subramaiam, Wan-Loy Chu, Ammu Kutty Radhakrishnan, Srikumar Chakravarthi, Kanga Rani Selvaduray & Yih-Yih Kok. (2021) Evaluating Anticancer and Immunomodulatory Effects of Spirulina (Arthrospira) platensis and Gamma-Tocotrienol Supplementation in a Syngeneic Mouse Model of Breast Cancer. Nutrients 13:7, pages 2320.
Crossref
Crossref
Markus Kuksis, Yizhuo Gao, William Tran, Christianne Hoey, Alex Kiss, Adam S Komorowski, Aman J Dhaliwal, Arjun Sahgal, Sunit Das, Kelvin K Chan & Katarzyna J Jerzak. (2021) The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis. Neuro-Oncology 23:6, pages 894-904.
Crossref
Crossref
Daniele Galanti, Alessandro Inno, Maria La Vecchia, Nicolò Borsellino, Lorena Incorvaia, Antonio Russo & Stefania Gori. (2021) Current treatment options for HER2-positive breast cancer patients with brain metastases. Critical Reviews in Oncology/Hematology 161, pages 103329.
Crossref
Crossref
Tomohiko Sano, Xun Sun, Yan Feng, Shengzhi Liu, Misato Hase, Yao Fan, Rongrong Zha, Di Wu, Uma K. Aryal, Bai-Yan Li, Akihiro Sudo & Hiroki Yokota. (2021) Inhibition of the Growth of Breast Cancer-Associated Brain Tumors by the Osteocyte-Derived Conditioned Medium. Cancers 13:5, pages 1061.
Crossref
Crossref
Anders Wilder Erickson, Steven Habbous, Christianne Hoey, Katarzyna J. Jerzak & Sunit Das. (2021) Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis. npj Breast Cancer 7:1.
Crossref
Crossref
Chao Gao, Fuchenchu Wang, Dima Suki, Eric Strom, Jing Li, Raymond Sawaya, Limin Hsu, Akshara Raghavendra, Debu Tripathy & Nuhad K. Ibrahim. (2020)
Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain:
MD
Anderson Cancer Center experience
. International Journal of Cancer 148:4, pages 961-970.
Crossref
Crossref
Xue Bai, Xue Lin, Jin Song, Jia-han Chang, Li-li Han & Cibo Fan. (2021) Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis. Clinics 76, pages e2653.
Crossref
Crossref
L. Klint, A. Kovács, E. Rönnerman & B. Linderholm. (2021) Real world data on adjuvant treatment of older HER2-positive breast cancer patients – A single institution experience through 8 years. Cancer Treatment and Research Communications 28, pages 100430.
Crossref
Crossref
Yongming Xu, Yanrong Zhu, Yong Yue, Shaofeng Pu, Junzhen Wu, Yingying Lv & Dongping Du. (2020) Tamoxifen attenuates reactive astrocyte-induced brain metastasis and drug resistance through the IL-6/STAT3 signaling pathway. Acta Biochimica et Biophysica Sinica 52:12, pages 1299-1305.
Crossref
Crossref
Maria Rita Dionísio, André F. Vieira, Rita Carvalho, Inês Conde, Mónica Oliveira, Madalena Gomes, Marta T. Pinto, Pedro Pereira, José Pimentel, Cristiano Souza, Márcia M. C. Marques, Vinícius Duval da Silva, Alison Barroso, Daniel Preto, Jorge F. Cameselle-Teijeiro, Fernando Schmitt, Ana Sofia Ribeiro & Joana Paredes. (2020) BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer. Cells 9:11, pages 2442.
Crossref
Crossref
Lola Koniali, Andreas Hadjisavvas, Anastasia Constantinidou, Kyproula Christodoulou, Yiolanda Christou, Christiana Demetriou, Andreas S. Panayides, Constantinos Pitris, Constantinos S. Pattichis, Eleni Zamba-Papanicolaou & Kyriacos Kyriacou. (2020) Risk factors for breast cancer brain metastases: a systematic review. Oncotarget 11:6, pages 650-669.
Crossref
Crossref
Adam S. Komorowski, Ellen Warner, Helen J. MacKay, Arjun Sahgal, Kathleen I. Pritchard & Katarzyna J. Jerzak. (2020) Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening?. Clinical Breast Cancer 20:1, pages e54-e64.
Crossref
Crossref
Franziska M. Ippen, Elisa Aquilanti, Helen D’Couto, Julia Grosch & Priscilla K. Brastianos. 2020. Central Nervous System Metastases. Central Nervous System Metastases
43
58
.
Linda Dirven & Martin J. B. Taphoorn. 2020. Central Nervous System Metastases. Central Nervous System Metastases
3
14
.
Mariko Asaoka, Kazutaka Narui, Nobuyasu Suganuma, Takashi Chishima, Akimitsu Yamada, Sadatoshi Sugae, Saori Kawai, Natsuki Uenaka, Saeko Teraoka, Kana Miyahara, Takahiko Kawate, Eichi Sato, Toshitaka Nagao, Yuka Matsubara, Shipra Gandhi, Kazuaki Takabe & Takashi Ishikawa. (2019) Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy. European Journal of Surgical Oncology 45:12, pages 2289-2294.
Crossref
Crossref
Kaelin O’Connell, Carlos G. Romo & Stuart A. Grossman. (2019) Brain Metastases as a First Site of Recurrence in Patients Receiving Chemotherapy with Controlled Systemic Cancer: a Critical but Under-Recognized Clinical Scenario. Current Treatment Options in Neurology 21:11.
Crossref
Crossref
Tan To Cheung, Kenneth SH Chok, Albert CY Chan, Simon HY Tsang, Wing Chiu Dai, Thomas CC Yau, Ava Kwong & Chung Mau Lo. (2019) Survival analysis of breast cancer liver metastasis treated by hepatectomy: A propensity score analysis for Chinese women in Hong Kong. Hepatobiliary & Pancreatic Diseases International 18:5, pages 452-457.
Crossref
Crossref
Anders W. Erickson & Sunit Das. (2019) The Impact of Targeted Therapy on Intracranial Metastatic Disease Incidence and Survival. Frontiers in Oncology 9.
Crossref
Crossref
Kevin Armstrong, Jennifer Ward, Mary Dunne, Luke Rock, Jennifer Westrup, Christopher R. Mascott, Pierre Thirion & Alina Mihaela Mihai. (2019) Linac-Based Radiosurgery for Patients With Brain Oligometastases From a Breast Primary, in the Trastuzumab Era-Impact of Tumor Phenotype and Prescribed SRS Dose. Frontiers in Oncology 9.
Crossref
Crossref
Joanne W Chiu, Roland Leung, Vikki Tang, Wai Yin Cheuk, Jessica Lo, Gin Wai Kwok, Hilda Wong, Dacita Suen, Polly Cheung, Ting Ting Wong, Thomas Yau & Ava Kwong. (2019) Changing pattern of recurrences in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy in the era of dual anti-HER2 therapy. Postgraduate Medical Journal 95:1121, pages 155-161.
Crossref
Crossref
Haiyang Su, Zhenyang Lin, Weicheng Peng & Zhiqiang Hu. (2018) Identification of potential biomarkers of lung adenocarcinoma brain metastases via microarray analysis of cDNA expression profiles. Oncology Letters.
Crossref
Crossref
I. Witzel, E. Laakmann, R. Weide, T. Neunhöffer, T.-J. Park-Simon, M. Schmidt, P.A. Fasching, T. Hesse, A. Polasik, S. Mohrmann, F. Würschmidt, C. Schem, C. Bechtner, R. Würstlein, T. Fehm, V. Möbus, N. Burchardi, S. Loibl & V. Müller. (2018) Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry. European Journal of Cancer 102, pages 1-9.
Crossref
Crossref
David M. Routman, Shelly X. Bian, Kevin Diao, Jonathan L. Liu, Cheng Yu, Jason Ye, Gabriel Zada & Eric L. Chang. (2018) The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery. Cancer Medicine 7:3, pages 757-764.
Crossref
Crossref
Lokesh Dalasanur Nagaprashantha, Ramesh Adhikari, Jyotsana Singhal, Shireen Chikara, Sanjay Awasthi, David Horne & Sharad S. Singhal. (2017) Translational opportunities for broad‐spectrum natural phytochemicals and targeted agent combinations in breast cancer. International Journal of Cancer 142:4, pages 658-670.
Crossref
Crossref
Adel Samson, Karen J. ScottDavid Taggart, Emma J. WestErica Wilson, Gerard J. Nuovo, Simon Thomson, Robert CornsRyan K. Mathew, Martin J. FullerTimothy J. KottkeJill M. ThompsonElizabeth J. Ilett, Julia V. Cockle, Philip van HilleGnanamurthy SivakumarEuan S. PolsonSamantha J. Turnbull, Elizabeth S. AppletonGemma MignecoAilsa S. Rose, Matthew C. CoffeyDeborah A. Beirne, Fiona J. CollinsonChristy Ralph, D. Alan Anthoney, Christopher J. TwelvesAndrew J. FurnessSergio A. Quezada, Heiko Wurdak, Fiona Errington-Mais, Hardev PandhaKevin J. HarringtonPeter J. Selby, Richard G. VileStephen D. Griffin, Lucy F. Stead, Susan C. Short & Alan A. Melcher. (2018) Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science Translational Medicine 10:422.
Crossref
Crossref
Herbert H. Engelhard, Gregory D. Arnone, Ankit I. Mehta & Martin K. Nicholas. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
113
125
.
Joo Yeon Nam & Barbara J. O’Brien. (2017) Current chemotherapeutic regimens for brain metastases treatment. Clinical & Experimental Metastasis 34:6-7, pages 391-399.
Crossref
Crossref
Arnaldo Marín, Alex Renner, Laura Itriago & Manuel Álvarez. (2017) METÁSTASIS CEREBRALES: UNA MIRADA BIOLÓGICA Y CLÍNICA. Revista Médica Clínica Las Condes 28:3, pages 437-449.
Crossref
Crossref
Ibiayi Dagogo-Jack, Corey M. Gill, Daniel P. Cahill, Sandro Santagata & Priscilla K. Brastianos. (2017) Treatment of brain metastases in the modern genomic era. Pharmacology & Therapeutics 170, pages 64-72.
Crossref
Crossref
Vivien Chan, Arjun Sahgal, Peter Egeto, Tom Schweizer & Sunit Das. (2016) Incidence of seizure in adult patients with intracranial metastatic disease. Journal of Neuro-Oncology 131:3, pages 619-624.
Crossref
Crossref
Isabell Witzel, Leticia Oliveira-Ferrer, Klaus Pantel, Volkmar Müller & Harriet Wikman. (2016) Breast cancer brain metastases: biology and new clinical perspectives. Breast Cancer Research 18:1.
Crossref
Crossref
Thiele Kobus, Ioannis K. Zervantonakis, Yongzhi Zhang & Nathan J. McDannold. (2016) Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption. Journal of Controlled Release 238, pages 281-288.
Crossref
Crossref
Ji Yun Lee, Kyunghee Park, Eunjin Lee, TaeJin Ahn, Hae Hyun Jung, Sung Hee Lim, Mineui Hong, In-Gu Do, Eun Yoon Cho, Duk-Hwan Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im & Yeon Hee Park. (2016) Gene Expression Profiling of Breast Cancer Brain Metastasis. Scientific Reports 6:1.
Crossref
Crossref
William Jacot, Elvire Pons, Jean-Sébastien Frenel, Séverine Guiu, Christelle Levy, Pierre Etienne Heudel, Thomas Bachelot, Véronique D’Hondt, Amélie Darlix, Nelly Firmin, Gilles Romieu, Simon Thezenas & Florence Dalenc. (2016) Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases. Breast Cancer Research and Treatment 157:2, pages 307-318.
Crossref
Crossref
Renata Duchnowska & Jacek Jassem. 2016. Brain Metastases from Primary Tumors, Volume 3. Brain Metastases from Primary Tumors, Volume 3
225
236
.
Kenichi Inoue, Katsumasa Kuroi, Satoru Shimizu, Yoshiaki Rai, Kenjiro Aogi, Norikazu Masuda, Takahiro Nakayama, Hiroji Iwata, Yuichiro Nishimura, Alison Armour & Yasutsuna Sasaki. (2015) Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer. International Journal of Clinical Oncology 20:6, pages 1102-1109.
Crossref
Crossref
Muhammet Ali Kaplan, Hamza Ertugrul, Ugur Firat, Mehmet Kucukoner, Ali İnal, Zuhat Urakci, Zafer Pekkolay & Abdurrahman Isikdogan. (2014) Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab. Breast Cancer 22:5, pages 503-509.
Crossref
Crossref
Xavier PivotAlexey ManikhasBogdan ŻurawskiEwa ChmielowskaBoguslawa KaraszewskaRozenn AllertonStephen ChanAlessandra FabiPaolo BidoliStefania GoriEva CiruelosMagdolna DankLajos HornyakSara MargolinArnd NuschRoma ParikhFareha NagiMichelle DeSilvioSergio SantillanaRamona F. SwabyVladimir Semiglazov. (2015) CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Journal of Clinical Oncology 33:14, pages 1564-1573.
Crossref
Crossref
Akbar Hedayatizadeh-Omran, Alireza Rafiei, Reza Alizadeh-Navaei, Mohsen Tehrani, Reza Valadan, Kambiz Moradzadeh, Mohammad Panbechi & Seyed Mehdi Taghavi. (2015) Role of HER2 in Brain Metastasis of Breast Cancer: a Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention 16:4, pages 1431-1434.
Crossref
Crossref
Richard De Boer, Jane Beith, Jacquie Chirgwin, Sue Chua, Maree Colosimo, Prudence Francis, Michael Green, Ken Pittman, Michelle White, Nicholas Wilcken, Nicholas Zdenkowski & Richard Bell. (2014) Systemic treatment of HER2+ metastatic breast cancer: Clinical conundrums and future perspectives. Asia-Pacific Journal of Clinical Oncology 10, pages 15-25.
Crossref
Crossref
Jaclyn J. Renfrow & Glenn J. Lesser. (2013) Molecular Subtyping of Brain Metastases and Implications for Therapy. Current Treatment Options in Oncology 14:4, pages 514-527.
Crossref
Crossref
Nina Martinez, Adrienne Boire & Lisa DeAngelis. (2013) Molecular Interactions in the Development of Brain Metastases. International Journal of Molecular Sciences 14:8, pages 17157-17167.
Crossref
Crossref
Ines Vaz-Luis, Davinia Seah, Erin M. Olson, Nikhil Wagle, Otto Metzger-Filho, Jessica Sohl, Georgia Litsas, Harold J. Burstein, Ian E. Krop, Eric P. Winer & Nancy U. Lin. (2013) Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study. Clinical Breast Cancer 13:4, pages 254-263.
Crossref
Crossref
Hiroji Iwata, Masaru Narabayashi, Yoshinori Ito, Shigehira Saji, Yasuhiro Fujiwara, Shigeyuki Usami, Koichi Katsura & Yasutsuna Sasaki. (2012) A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients. International Journal of Clinical Oncology 18:4, pages 621-628.
Crossref
Crossref
Ankit I. Mehta, Adam M. Brufsky & John H. Sampson. (2013) Therapeutic approaches for HER2-positive brain metastases: Circumventing the blood–brain barrier. Cancer Treatment Reviews 39:3, pages 261-269.
Crossref
Crossref
Shoji Yomo, Motohiro Hayashi & Narisumi Cho. (2013) Impacts of HER2-overexpression and molecular targeting therapy on the efficacy of stereotactic radiosurgery for brain metastases from breast cancer. Journal of Neuro-Oncology 112:2, pages 199-207.
Crossref
Crossref
Rupert Bartsch, Anna S. Berghoff & Matthias Preusser. (2012) Optimal Management of Brain Metastases from Breast Cancer. CNS Drugs 27:2, pages 121-134.
Crossref
Crossref
Mustafa Oktay Tarhan, Lutfiye Demir, Isil Somali, Seyran Yigit, Cigdem Erten, Ahmet Alacacioglu, Hulya Ellidokuz, Ozgur Seseogullari, Yuksel Kucukzeybek, Alper Can, Ahmet Dirican, Vedat Bayoglu & Murat Akyol. (2012) The clinicopathological evaluation of the breast cancer patients with brain metastases: predictors of survival. Clinical & Experimental Metastasis 30:2, pages 201-213.
Crossref
Crossref
A. Jo Chien & Hope S. Rugo. (2012) Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment 137:1, pages 1-12.
Crossref
Crossref
Yvonne Kienast. 2013. Experimental Metastasis: Modeling and Analysis. Experimental Metastasis: Modeling and Analysis
93
115
.
Mi-Ran Choi, Rizia Bardhan, Katie J. Stanton-Maxey, Sunil Badve, Harikrishna Nakshatri, Keith M. Stantz, Ning Cao, Naomi J. Halas & Susan E. Clare. (2012) Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse. Cancer Nanotechnology 3:1-6, pages 47-54.
Crossref
Crossref
Riccardo Soffietti, Elisa Trevisan & Roberta Rudà. (2012) Targeted therapy in brain metastasis. Current Opinion in Oncology 24:6, pages 679-686.
Crossref
Crossref
Y S Yap, G H Cornelio, B C R Devi, C Khorprasert, S B Kim, T Y Kim, S C Lee, Y H Park, J H Sohn, N Sutandyo, D W Y Wong, M Kobayashi, S H Landis, E M Yeoh, H Moon & J Ro. (2012) Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival. British Journal of Cancer 107:7, pages 1075-1082.
Crossref
Crossref
Zhiyuan Xu, Nicholas F. Marko, Sam T. Chao, Lilyana Angelov, Michael A. Vogelbaum, John H. Suh, Gene H. Barnett & Robert J. Weil. (2012) Relationship Between HER2 Status and Prognosis in Women With Brain Metastases From Breast Cancer. International Journal of Radiation Oncology*Biology*Physics 82:5, pages e739-e747.
Crossref
Crossref
Rachel A. Freedman & Carey K. Anders. (2011) Treatment of Breast Cancer Brain Metastases. Current Breast Cancer Reports 4:1, pages 1-9.
Crossref
Crossref
Joseph A. Bovi & Julia White. (2011) Radiation Therapy in the Prevention of Brain Metastases. Current Oncology Reports 14:1, pages 55-62.
Crossref
Crossref
Lakshmi Nayak, Eudocia Quant Lee & Patrick Y. Wen. (2011) Epidemiology of Brain Metastases. Current Oncology Reports 14:1, pages 48-54.
Crossref
Crossref
Mark D. Danese, Karla Lindquist, Justin Doan, Deepa Lalla, Melissa Brammer & Robert I. Griffiths. (2012) Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer. Journal of Cancer Epidemiology 2012, pages 1-9.
Crossref
Crossref
R Bartsch, A Berghoff, U Pluschnig, Z Bago-Horvath, P Dubsky, A Rottenfusser, C DeVries, M Rudas, F Fitzal, K Dieckmann, R M Mader, M Gnant, C C Zielinski & G G Steger. (2011) Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases. British Journal of Cancer 106:1, pages 25-31.
Crossref
Crossref
Farheen Arshad, Lili Wang, Christopher Sy, Shalom Avraham & Hava Karsenty Avraham. (2011) Blood-Brain Barrier Integrity and Breast Cancer Metastasis to the Brain. Pathology Research International 2011, pages 1-12.
Crossref
Crossref
Dionysis Papadatos-Pastos & Udai Banerji. (2011) Revisiting the role of molecular targeted therapies in patients with brain metastases. Journal of Neuro-Oncology 105:3, pages 467-474.
Crossref
Crossref
Hilda Wong, Roland Leung, Ava KwongJoanne Chiu, Raymond Liang, Charles Swanton & Thomas Yau. (2011) Integrating Molecular Mechanisms and Clinical Evidence in the Management of Trastuzumab Resistant or Refractory HER-2+ Metastatic Breast Cancer. The Oncologist 16:11, pages 1535-1546.
Crossref
Crossref
Antonino Musolino, Laura Ciccolallo, Michele Panebianco, Elisa Fontana, Daniele Zanoni, Cecilia Bozzetti, Maria Michiara, Enrico Maria Silini & Andrea Ardizzoni. (2010) Multifactorial central nervous system recurrence susceptibility in patients with HER2‐positive breast cancer. Cancer 117:9, pages 1837-1846.
Crossref
Crossref
Isabell Witzel, Eva Johanna Kantelhardt, Karin Milde-Langosch, Maike Ihnen, Julia Zeitz, Nadia Harbeck, Fritz Jänicke & Volkmar Müller. (2011) Management of Patients with Brain Metastases Receiving Trastuzumab Treatment for Metastatic Breast Cancer. Onkologie 34:6, pages 304-308.
Crossref
Crossref
S. Dawood, N.T. Ueno, V. Valero, E. Andreopoulou, L. Hsu, J. Lara, W. Woodward, T.A. Buchholz, G.N. Hortobagyi & M. Cristofanilli. (2010) Incidence of and survival following brain metastases among women with inflammatory breast cancer. Annals of Oncology 21:12, pages 2348-2355.
Crossref
Crossref
Anna Niwińska, Małgorzata Tacikowska & Magdalena Murawska. (2010) The Effect of Early Detection of Occult Brain Metastases in HER2-Positive Breast Cancer Patients on Survival and Cause of Death. International Journal of Radiation Oncology*Biology*Physics 77:4, pages 1134-1139.
Crossref
Crossref
Angélique P. J. M. Braen, Josée Perron, Pierre Tellier, Anthony R. Catala, Gerry Kolaitis & Wanping Geng. (2010) A 4-Week Intrathecal Toxicity and Pharmacokinetic Study With Trastuzumab in Cynomolgus Monkeys. International Journal of Toxicology 29:3, pages 259-267.
Crossref
Crossref
A. Niwińska, M. Murawska & K. Pogoda. (2010) Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Annals of Oncology 21:5, pages 942-948.
Crossref
Crossref
T. Pieńkowski & C.C. Zielinski. (2010) Trastuzumab treatment in patients with breast cancer and metastatic CNS disease. Annals of Oncology 21:5, pages 917-924.
Crossref
Crossref
Olivier GraesslinBassam S. AbdulkarimCharles CoutantFlorence HuguetZsolt GabosLimin HsuOlivier MarpeauSerge UzanLajos PusztaiEric A. StromGabriel N. HortobagyiRoman RouzierNuhad K. Ibrahim. (2010) Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer. Journal of Clinical Oncology 28:12, pages 2032-2037.
Crossref
Crossref
J-S FrenelE BourboulouxD Berton-RigaudS Sadot-LebouvierA ZanettiM Campone. (2009) Lapatinib in Metastatic Breast Cancer. Women's Health 5:6, pages 603-612.
Crossref
Crossref
Brian Leyland-Jones. (2009) Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Central Nervous System Metastases. Journal of Clinical Oncology 27:31, pages 5278-5286.
Crossref
Crossref
Renata Duchnowska, Rafał Dziadziuszko, Bogumiła Czartoryska-Arłukowicz, Barbara Radecka, Barbara Szostakiewicz, Katarzyna Sosińska-Mielcarek, Agnieszka Karpińska, Elżbieta Starosławska, Tomasz Kubiatowski & Cezary Szczylik. (2009) Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Research and Treatment 117:2, pages 297-303.
Crossref
Crossref
Riccardo Soffietti, Wallace Akerley, Randy L. Jensen, Joachim Bischoff & Anne Constanze Regierer. (2009) The Role of Intra-cerebrospinal Fluid Treatment and Prophylaxis in Patients With Solid Tumors. Seminars in Oncology 36, pages S55-S68.
Crossref
Crossref
M. Untch & C. Jackisch. (2009) Behandlung der Patientinnen mit HER2- (ErbB2-) positivem MammakarzinomTreatment of patients with HER2 (erbB2) positive breast cancer. Der Onkologe 15:8, pages 811-826.
Crossref
Crossref
Peter S Hall, Jaishree Bhosle & David A Cameron. (2009) Lapatinib in the management of breast cancer. Therapy 6:4, pages 553-568.
Crossref
Crossref
Y H Park, M J Park, S H Ji, S Y Yi, D H Lim, D H Nam, J-I Lee, W Park, D H Choi, S J Huh, J S Ahn, W K Kang, K Park & Y-H Im. (2009) Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. British Journal of Cancer 100:6, pages 894-900.
Crossref
Crossref
Fleur Huang, Munir Alrefae, Adrian Langleben & David Roberge. (2009) Prophylactic Cranial Irradiation in Advanced Breast Cancer: A Case for Caution. International Journal of Radiation Oncology*Biology*Physics 73:3, pages 752-758.
Crossref
Crossref
Nancy U. Lin, Véronique Diéras, Devchand Paul, Dominique Lossignol, Christos Christodoulou, Hans-Joachim Stemmler, Henri Roché, Minetta C. Liu, Richard Greil, Eva Ciruelos, Sibylle Loibl, Stefania Gori, Andrew Wardley, Denise Yardley, Adam Brufsky, Joanne L. Blum, Stephen D. Rubin, Bernie Dharan, Klaudia Steplewski, Denise Zembryki, Cristina Oliva, Debasish Roychowdhury, Paolo Paoletti & Eric P. Winer. (2009) Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer. Clinical Cancer Research 15:4, pages 1452-1459.
Crossref
Crossref
Makiko Ono, Masashi Ando, Mayu Yunokawa, Eriko Nakano, Kan Yonemori, Koji Matsumoto, Tsutomu Kouno, Chikako Shimizu, Kenji Tamura, Noriyuki Katsumata & Yasuhiro Fujiwara. (2009) Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. International Journal of Clinical Oncology 14:1, pages 48-52.
Crossref
Crossref
David N. ChurchChris G.A. Price. (2009) A Review of Trastuzumab-Based Therapy in Patients with HER2-positive Metastatic Breast Cancer. Clinical Medicine. Therapeutics 1, pages CMT.S35.
Crossref
Crossref
Michelle E Melisko, Michael Glantz & Hope S Rugo. (2008) New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nature Clinical Practice Oncology 6:1, pages 25-33.
Crossref
Crossref
David A Cameron & Steven Stein. (2008) Drug Insight: intracellular inhibitors of HER2—clinical development of lapatinib in breast cancer. Nature Clinical Practice Oncology 5:9, pages 512-520.
Crossref
Crossref
Robert M. Sharkey & David M. Goldenberg. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Advanced Drug Delivery Reviews 60:12, pages 1407-1420.
Crossref
Crossref
Hans-Joachim Stemmler & Volker Heinemann. (2008) Central Nervous System Metastases in HER-2–Overexpressing Metastatic Breast Cancer: A Treatment Challenge. The Oncologist 13:7, pages 739-750.
Crossref
Crossref
Issa J. Dahabreh, Helen Linardou, Fotios Siannis, George Fountzilas & Samuel Murray. (2008) Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Oncologist 13:6, pages 620-630.
Crossref
Crossref
David N. Church, Ramayana Modgil, Sam Guglani, Amit Bahl, Kirsten Hopkins, Jeremy P. Braybrooke, Peter Blair & Chris G. A. Price. (2008) Extended Survival in Women With Brain Metastases From HER2 Overexpressing Breast Cancer. American Journal of Clinical Oncology 31:3, pages 250-254.
Crossref
Crossref
April F. Eichler, Irene Kuter, Paula Ryan, Lidia Schapira, Jerry Younger & John W. Henson. (2008) Survival in patients with brain metastases from breast cancer. Cancer 112:11, pages 2359-2367.
Crossref
Crossref
Gloria Roldán, James Scott, David George, Ian Parney, Jacob Easaw, Gregory Cairncross, Peter Forsyth & Elizabeth Yan. (2014) Leptomeningeal Disease from Oligodendroglioma: Clinical and Molecular Analysis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 35:2, pages 204-209.
Crossref
Crossref
Neil Spector. (2008) Treatment of Metastatic ErbB2-Positive Breast Cancer: Options After Progression on Trastuzumab. Clinical Breast Cancer 8, pages S94-S99.
Crossref
Crossref
Pierre Fumoleau. (2008) Future options in the treatment of ErbB2 (HER2)-positive breast cancer. European Journal of Cancer Supplements 6:5, pages 25-31.
Crossref
Crossref
Christian Jackisch. (2008) Challenges in the treatment of ErbB2 (HER2)-positive breast cancer. European Journal of Cancer Supplements 6:5, pages 7-14.
Crossref
Crossref
Elise M. Pelletier, Boyung Shim, Seth Goodman & Mayur M. Amonkar. (2007) Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis. Breast Cancer Research and Treatment 108:2, pages 297-305.
Crossref
Crossref
U. Liebeskind, F. Fitzal, R. Jakesz, W. DÖller & C. Ure. 2008. Chirurgische Onkologie. Chirurgische Onkologie
95
121
.
Xiaoyun Cheng & Mien-Chie Hung. (2007) Breast cancer brain metastases. Cancer and Metastasis Reviews 26:3-4, pages 635-643.
Crossref
Crossref
Stefania Gori, Simonetta Rimondini, Verena De Angelis, Mariantonietta Colozza, Giancarlo Bisagni, Gabriella Moretti, Angelo Sidoni, Carlo Basurto, Cynthia Aristei, Paola Anastasi & Lucio Crinò. (2007) Central Nervous System Metastases in HER-2–Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Incidence, Survival, and Risk Factors. The Oncologist 12:7, pages 766-773.
Crossref
Crossref
V. Adamo, T. Franchina, B. Adamo, G. Ferraro, R. Rossello, M. Maugeri Saccà, C. Scibilia, M.R. Valerio & A. Russo. (2007) Safety and activity of trastuzumab-containing therapies for the treatment of metastatic breast cancer: our long-term clinical experience (GOIM study). Annals of Oncology 18, pages vi11-vi15.
Crossref
Crossref
Teri D. Nguyen & Lauren E. Abrey. (2007) Brain Metastases: Old Problem, New Strategies. Hematology/Oncology Clinics of North America 21:2, pages 369-388.
Crossref
Crossref
Nancy U. Lin & Eric P. Winer. (2007) Brain Metastases: The HER2 Paradigm. Clinical Cancer Research 13:6, pages 1648-1655.
Crossref
Crossref
Adam I. Riker, SuHu Liu, Mona Hagmaier, Matthew J. D. D'lessio & Charles E. Cox. 2007. Metastasis of Breast Cancer. Metastasis of Breast Cancer
355
372
.